This mtDNA activates immune responses, exacerbating inflammation and cell death pathways. Histopathology studies of COVID-19 ...

Malignancies of lymphoid cells range from the most indolent to the most aggressive human malignancies and often compromise ...

The bird flu virus found in a severely ill patient hospitalized in the United States has mutated to become better adapted to ...

Immunology research has helped develop life-saving treatments for various diseases, including cancer, autoimmune disorders, ...

This manuscript provides valuable information about the genesis of CPSF6 condensates due to HIV-1 infection. However, the evidence is incomplete as it is missing more functional assays. Furthermore, ...

The Global ELISA Analyzers Market, valued at approximately USD 567.88 million in 2022, is projected to grow at a healthy CAGR of more than 3.7% during the forecast period from 2023 to 2030. ELISA ...

Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Osteosarcoma.

Dr. Ling Yin’s groundbreaking work with the ErbB/HER protein can potentially transform the fight against one of humanity’s deadliest diseases. As a ...

Millions of individuals are affected by cancer each year. In response, different organizations and the federal government heavily invest in research to dev | Immunology ...

Kim and her team used a protein-based therapy known as a cytokine-based therapy, which helps direct cell functions. Cytokines are proteins that are sent between cells to communicate. Many of these ...

点击上方“感染学苑” ...

A new antibody has been developed to block immune suppression in aggressive breast cancer, offering a promising treatment.